| 0 (0%) | 11-11 17:42 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 71.34 | 1-year : | 85.12 |
| Resists | First : | 61.08 | Second : | 72.87 |
| Pivot price | 59.99  |
|||
| Supports | First : | 41.99 | Second : | 34.93 |
| MAs | MA(5) : | 46.62 |
MA(20) : | 61.68 |
| MA(100) : | 70.98 |
MA(250) : | 63.44 |
|
| MACD | MACD : | -4.3 |
Signal : | -2 |
| %K %D | K(14,3) : | 18.2 |
D(3) : | 14 |
| RSI | RSI(14): 35.1 |
|||
| 52-week | High : | 90.31 | Low : | 41.5 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ SLNO ] has closed above bottom band by 20.8%. Bollinger Bands are 145.1% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 4 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 50.82 - 51.18 | 51.18 - 51.46 |
| Low: | 47.07 - 47.43 | 47.43 - 47.71 |
| Close: | 48.22 - 48.79 | 48.79 - 49.23 |
Tue, 11 Nov 2025
Johnson Fistel Begins Investigation on Behalf of Soleno - GlobeNewswire
Tue, 11 Nov 2025
Is SLNO stock trading at a premium valuation - Weekly Profit Report & Detailed Earnings Play Strategies - newser.com
Tue, 11 Nov 2025
Soleno Therapeutics Surges Past Q3 Forecasts, Revenue Hits High - timothysykes.com
Tue, 11 Nov 2025
Why Is Soleno Therapeutics Stock Surging Tuesday? - Soleno Therapeutics (NASDAQ:SLNO) - Benzinga
Tue, 11 Nov 2025
Soleno hits monthly high after $100 million share buyback deal - TradingView
Tue, 11 Nov 2025
Soleno Therapeutics, Inc. Announces $100 Million Share Repurchase through Accelerated Share Repurchase Agreement - Quiver Quantitative
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 53 (M) |
| Shares Float | 45 (M) |
| Held by Insiders | 1.8 (%) |
| Held by Institutions | 109.7 (%) |
| Shares Short | 8,440 (K) |
| Shares Short P.Month | 7,250 (K) |
| EPS | -4.22 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 4.76 |
| Profit Margin | 0 % |
| Operating Margin | -16.7 % |
| Return on Assets (ttm) | -36.6 % |
| Return on Equity (ttm) | -69.6 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0.6 |
| Sales Per Share | 0.61 |
| EBITDA (p.s.) | -3.47 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -84 (M) |
| Levered Free Cash Flow | -23 (M) |
| PE Ratio | -11.55 |
| PEG Ratio | 0 |
| Price to Book value | 10.23 |
| Price to Sales | 79.25 |
| Price to Cash Flow | -30.72 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|